Current antihypertensive drug therapy in 12,436 Swedish patients, 90 years and above, in relation to sex and comorbidity

References

• Kahan T, de Faire U, Hedblad B, et al. Moderately elevated blood pressure: a systematic literature review. Stockholm: The Swedish Council on Technology Assessment in Health Care; 2004–2007. p. 1–195.
   Google Scholar
• NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19.1 million participants. Lancet. 2016;389(10064):37–55.
   PubMed Web of Science ®Google Scholar
• Wolf-Maier K, Cooper RS, Banegas JR, et al. Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA. 2003;289(18):2363–2369.
   PubMed Web of Science ®Google Scholar
• Ettehad D, Emdin CA, Kiran A, et al. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet. 2016;387(10022):957–967.
   PubMed Web of Science ®Google Scholar
• Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ. 2009;338:b1665.
   PubMed Web of Science ®Google Scholar
• Thomopoulos C, Parati G, Zanchetti A. Effects of blood pressure lowering on outcome incidence in hypertension. 1. Overview, meta-analyses, and meta-regression analyses of randomized trials. J Hypertens. 2014;32(12):2285–2295.
   PubMed Web of Science ®Google Scholar
• Ljungman C, Mortensen L, Kahan T, et al. Treatment of mild to moderate hypertension by gender perspective: a systematic review. J Womens Health. 2009;18(7):1049–1062.
   PubMed Web of Science ®Google Scholar
• Turnbull F, Woodward M, Neal B, et al. Do men and women respond differently to blood pressure-lowering treatment? Results of prospectively designed overviews of randomized trials. Eur Heart J. 2008;29(21):2669–2680.
   PubMed Web of Science ®Google Scholar
• Beckett NS, Peters R, Fletcher AE, et al. Treatment of hypertension in patients 80 years of age or older. N Engl J Med. 2008;358(18):1887–1898.
   PubMed Web of Science ®Google Scholar
• Thomopoulos C, Parati G, Zanchetti A. Effects of blood pressure-lowering treatment on cardiovascular outcomes and mortality: 13 – benefits and adverse events in older and younger patients with hypertension: overview, meta-analyses and meta-regression analyses of randomized trials. J Hypertens. 2018;36(8):1622–1636.
   PubMed Web of Science ®Google Scholar
• Beckett N, Peters R, Leonetti G, et al. Subgroup and per-protocol analyses from the hypertension in the very elderly trial. J Hypertens. 2014;32(7):1478–1487.
   PubMed Web of Science ®Google Scholar
• Corrao G, Rea F, Monzio Compagnoni M, et al. Protective effects of antihypertensive treatment in patients aged 85 years or older. J Hypertens. 2017;35(7):1432–1441.
   PubMedGoogle Scholar
• Warwick J, Falaschetti E, Rockwood K, et al. No evidence that frailty modifies the positive impact of antihypertensive treatment in very elderly people: an investigation of the impact of frailty upon treatment effect in the Hypertension in the Very Elderly Trial (HYVET) study, a double-blind, placebo-controlled study of antihypertensives in people with hypertension aged 80 and over. BMC Med. 2015;13:78.
   PubMed Web of Science ®Google Scholar
• Swedish National Statistics. 2016. [cited 2017 May 10]. Available from: http://www.scb.se/hitta-statistik/statistik-efter-amne/levnadsforhallanden/levnadsforhallanden/undersokningarna-av-levnadsforhallanden-ulf-silc/pong/tabell-och-diagram/halsa/halsa–fler-indikatorer-19802015/
   Google Scholar
• Wandell P, Carlsson AC, Wettermark B, et al. Most common diseases diagnosed in primary care in Stockholm, Sweden, in 2011. Fam Pract. 2013;30(5):506–513.
   PubMed Web of Science ®Google Scholar
• Lehnert T, Heider D, Leicht H, et al. Review: health care utilization and costs of elderly persons with multiple chronic conditions. Med Care Res Rev. 2011;68(4):387–420.
   PubMed Web of Science ®Google Scholar
• McPhail SM. Multimorbidity in chronic disease: impact on health care resources and costs. Risk Manag Healthc Policy. 2016;9:143–156.
   PubMed Web of Science ®Google Scholar
• National Clinical Guideline Centre. National Institute for Health and Clinical Excellence: Guidance. Hypertension: the clinical management of primary hypertension in adults: update of clinical guidelines 18 and 34. London: National Clinical Guideline Centre, Royal College of Physicians (UK); 2011.
   Google Scholar
• Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2018;71(19):e127–e248.
   PubMed Web of Science ®Google Scholar
• Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. Blood Pressure. 2018;27(6):314–340.
   PubMed Web of Science ®Google Scholar
• Wettermark B, Godman B, Neovius M, et al. Initial effects of a reimbursement restriction to improve the cost-effectiveness of antihypertensive treatment. Health Policy. 2010;94(3):221–229.
   PubMed Web of Science ®Google Scholar
• Wallentin F, Wettermark B, Kahan T. Drug treatment of hypertension in Sweden in relation to sex, age, and comorbidity. J Clin Hypertens. 2018;20(1):106–114.
   Web of Science ®Google Scholar
• Zarrinkoub R, Wettermark B, Wandell P, et al. The epidemiology of heart failure, based on data for 2.1 million inhabitants in Sweden. Eur J Heart Fail. 2013;15(9):995–1002.
   PubMed Web of Science ®Google Scholar
• Ludvigsson JF, Otterblad-Olausson P, Pettersson BU, et al. The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research. Eur J Epidemiol. 2009;24(11):659–667.
   PubMed Web of Science ®Google Scholar
• Ludvigsson JF, Andersson E, Ekbom A, et al. External review and validation of the Swedish national inpatient register. BMC Public Health. 2011;11(1):450.
   PubMed Web of Science ®Google Scholar
• Wettermark B, Hammar N, Fored CM, et al. The new Swedish Prescribed Drug Register – opportunities for pharmacoepidemiological research and experience from the first six months. Pharmacoepidemiol Drug Saf. 2007;16(7):726–735.
   PubMed Web of Science ®Google Scholar
• Holmquist C, Hasselstrom J, Bengtsson Bostrom K, et al. Improved treatment and control of hypertension in Swedish primary care: results from the Swedish primary care cardiovascular database. J Hypertens. 2017;35(10):2102–2108.
   PubMed Web of Science ®Google Scholar
• Qvarnstrom M, Kahan T, Kieler H, et al. Persistence to antihypertensive drug classes: a cohort study using the Swedish Primary Care Cardiovascular Database (SPCCD). Medicine. 2016;95(40):e4908.
   PubMed Web of Science ®Google Scholar
• Forslund T, Wettermark B, Wandell P, et al. Risk scoring and thromboprophylactic treatment of patients with atrial fibrillation with and without access to primary healthcare data: experience from the Stockholm health care system. Int J Cardiol. 2013;170(2):208–214.
   PubMed Web of Science ®Google Scholar
• Welsh TJ, Gladman JR, Gordon AL. The treatment of hypertension in people with dementia: a systematic review of observational studies. BMC Geriatr. 2014;14(1):19.
   PubMedGoogle Scholar
• Gardner RC, Valcour V, Yaffe K. Dementia in the oldest old: a multi-factorial and growing public health issue. Alzheimers Res Ther. 2013;5(4):27.
   PubMed Web of Science ®Google Scholar